. Similarly, another group showed embryonic blastula, and this small group of cells (13 at that the exposure of ES cells to retinoic acid prompted the 64 cell stage embryo) will normally give rise to the them to produce glutaminergic, GABAergic, and glyentire embryonic yolk sac, the allantois, and the amnion. fetuses, replacement therapy is not routinely available.
Other sources of dopamine producing cells, including neurons, and 7% serotonergic neurons. At the cellular level, the authors find that 53% of the cells in the culture those from the adrenal medulla or carotid bodies have been examined for their ability to alleviate Parkinson's were tubulinϩ neurons, and that 30% of these are dopaminergic. Thus, DA neurons represent 16% of the total symptoms, but these sources are also limited in numbers, and/or are not as effective as fetal DA neurons cell population. While coculture of the ES cells with the PA6 cell line induces neural differentiation, conditioned (Rosenthal, 1998 ). An unlimited source of DA neurons produced in vitro is needed to make transplantation media from PA6 cells does not. However, SDIA is also not blocked by a 0.4 m membrane barrier, suggesting available to a larger population of PD patients and could eventually change the transplantation landscape.
that the inducing activity is secreted, but may be labile. 
the SDIA-treated ES cells suggests a direct influence of
After destroying a subset of neocortical neurons that project to thalamus, these authors observed that a small, at least one of the SDIA activities on the production of DA neurons or midbrain neuroectoderm from ES cells. but significant number of new neurons were generated in the damaged region, and some reinnervated the thalaSince ES cells that were exposed to SDIA give rise also to GABAergic, cholinergic, and serotonergic neurons, mus. Whether the new neurons migrated from the subventricular zone or were generated locally from cortical they may be a useful source of transplanted neurons in other neurodegenerative disorders such as Huntingstem cells is not known. There is as yet no evidence that SDIA can promote the differentiation of neuronal ton disease, which is associated with degeneration of GABAergic interneurons in the striatum. 
